Improving equitable access for effective antibacterial: an ecosystem approach
Antibiotics are indispensable to modern healthcare, yet their equitable access remains a pressing global challenge. Factors contributing to inequities include insufficient evidence for optimal clinical use, limited registration, pricing for Reserve antibiotics, and supply chain challenges. These issues disproportionately affect low- and middle-income countries, exacerbating antimicrobial resistance burdens.
This paper explores the multifaceted dimensions of inequitable antibiotic access and proposes a comprehensive framework to address the crisis.
Authors
Jennifer Cohn, Manica Balasegaram, Hema Srinivasan, Leena Menghaney, Mirfin Mpundu, Brenda Waning, Yewande Alimi